Table 1:
Baseline demographics and propensity to undergo Hepatitis C virus (HCV) antibody screening among clients within a mobile medical clinic (MMC) in New Haven, Connecticut, 2012-2013 (N=1345).
| Correlate | Total Patients Seen N=1345 |
HCV Screening Performed | Screened vs Not Screened | ||||
|---|---|---|---|---|---|---|---|
| Yes N=438 |
No N=907 |
||||||
| N observed (95% CI) | N imputed (%) | N observed (95% CI) | N imputed (%) | N observed (95% CI) | N imputed (%) | p-value | |
| Mean Age, years [S.D.] | 37.5 | 37.5 | 35.6 | 35.6 | 38.5 | 38.5 | <0.01 |
| (36.9,38.2) | [12.0] | (34.5,36.7) | [11.7] | (37.7,39.3) | [12.1] | ||
| Baby boomer generation | 278 | 294 | 57 | 74 | 221 | 221 | <0.01 |
| (263,324) | 21.8% | (58,90) | 16.8% | (196,246) | 24.4% | ||
| Gender | |||||||
| Male | 738 | 751 | 242 | 256 | 496 | 497 | 0.220 |
| (715,788) | 55.8% | (235,277) | 58.4% | (467,526) | 54.7% | ||
| Female | 607 | 594 | 196 | 182 | 411 | 410 | 0.220 |
| (557,630) | 44.2% | (161,203) | 41.6% | (381,440) | 45.3% | ||
| Race | |||||||
| White | 347 | 359 | 89 | 99 | 258 | 258 | 0.028 |
| (326,391) | 26.7% | (81,117) | 22.6% | (231,285) | 28.4% | ||
| Black | 528 | 546 | 175 | 195 | 353 | 353 | 0.050 |
| (510,582) | 40.6% | (173,216) | 44.5% | (324,382) | 38.9% | ||
| Hispanic | 411 | 425 | 126 | 142 | 285 | 285 | 0.644 |
| (391,459) | 31.6% | (121,163) | 32.4% | (258,312) | 31.4% | ||
| Foreign-born | 671 | 711 | 147 | 183 | 524 | 524 | <0.01 |
| (673,748) | 52.8% | (160,207) | 41.8% | (495,553) | 57.7% | ||
| Unstable housing | 409 | 496 | 63 | 144 | 346 | 350 | 0.177 |
| (453,539) | 36.8% | (111,178) | 32.9% | (321,379) | 38.6% | ||
| No health insurance | 584 | 708 | 112 | 235 | 472 | 472 | 0.232 |
| (661,755) | 52.6% | (195,275) | 53.6% | (442,502) | 52.0% | ||
| Not in a stable relationship | 933 | 1146 | 173 | 383 | 760 | 764 | 0.315 |
| (1114,1177) | 85.2% | (358,407) | 87.3% | (742,785) | 84.2% | ||
| Prior diagnosis of hepatitis C | 46 | 46 | 23 | 26 | 23 | 23 | <0.01 |
| (33,60) | 3.4% | (15,37) | 5.9% | (14,32) | 2.5% | ||
| Prior STI diagnosis | 253 | 363 | 105 | 228 | 148 | 148 | 0.004 |
| (257,468) | 27.0% | (110,345) | 52.0% | (126,170) | 16.3% | ||
| Injection drug history (PWID) | 188 | 204 | 76 | 96 | 112 | 113 | <0.01 |
| (177,231) | 15.2% | (78,115) | 22.0% | (93,133) | 12.5% | ||
| Heroin | 203 | 268 | 39 | 108 | 164 | 164 | 0.015 |
| (237,300) | 20.0% | (86,130) | 24.7% | (141,187) | 18.0% | ||
| Cocaine | 345 | 435 | 70 | 164 | 275 | 275 | 0.070 |
| (393,476) | 32.3% | (131,196) | 37.4% | (248,302) | 30.3% | ||
| Use of | 38 | 57 | 7 | 28 | 31 | 31 | 0.380 |
| NSEP | (26,88) | 4.2% | (0,59) | 6.3% | (20,42) | 3.4% | |
| Crack cocaine use | 268 | 334 | 50 | 118 | 218 | 218 | 0.166 |
| (296,371) | 24.8% | (87,148) | 26.8% | (193,243) | 24.0% | ||
| Non-injection drug use | 514 | 625 | 106 | 218 | 408 | 408 | 0.096 |
| (585,665) | 46.4% | (193,242) | 49.6% | (379,437) | 45.0% | ||
| History of incarceration | 531 | 676 | 106 | 246 | 425 | 433 | 0.091 |
| (628,725) | 50.3% | (205,287) | 56.1% | (404,463) | 47.8% | ||
| History of interpersonal violence | 251 | 315 | 44 | 108 | 207 | 207 | 0.313 |
| (280,351) | 23.4% | (82,134) | 24.7% | (182,232) | 22.8% | ||
| MSM | 47 | 51 | 20 | 24 | 27 | 27 | 0.037 |
| (36,65) | 3.7% | (13,35) | 5.6% | (17,37) | 3.0% | ||
| Lifetime sexual partners > 15 | 133 | 145 | 133 | 155 | 0 | 0 | na |
| (121,168) | 10.7% | (134,175) | 35.3% | na | 0% | ||
Note: Nimputed is sample size based on the frequency estimate from multiple imputation procedure. Cocaine and heroin numbers reflect total users of either intravenous, oral, or inhaled routes.
LEGEND: HCV: Hepatitis C Virus; NSEP: Needle Syringe Exchange Program; STI: Sexually Transmitted Infection; PWID: People Who Inject Drugs; MSM: Men Who Have Sex with Men